| Schedule of earnings per share |
The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share attributable to common stockholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
2023 |
|
|
October 1,
2022 |
|
|
October 2,
2021 |
|
(In thousands, except share and per share data) |
|
|
|
|
|
|
|
|
|
Numerator: |
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to common stockholders - basic and diluted |
|
$ |
(10,274 |
) |
|
$ |
67,383 |
|
|
$ |
158,595 |
|
Denominator: |
|
|
|
|
|
|
|
|
|
Weighted-average shares of common stock - basic |
|
|
127,702,885 |
|
|
|
127,691,030 |
|
|
|
122,245,212 |
|
Effect of potentially dilutive stock options |
|
|
— |
|
|
|
5,472,807 |
|
|
|
10,120,238 |
|
Effect of RSUs |
|
|
— |
|
|
|
4,385,406 |
|
|
|
7,875,245 |
|
Effect of PSUs |
|
|
— |
|
|
|
212,835 |
|
|
|
68,457 |
|
Weighted-average shares of common stock—diluted |
|
|
127,702,885 |
|
|
|
137,762,078 |
|
|
|
140,309,152 |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share attributable to common stockholders: |
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
(0.08 |
) |
|
$ |
0.53 |
|
|
$ |
1.30 |
|
Diluted |
|
$ |
(0.08 |
) |
|
$ |
0.49 |
|
|
$ |
1.13 |
|
|
| Schedule of antidilutive securities |
The following potentially dilutive shares as of the end of each period presented were excluded from the computation of diluted net income (loss) per share for the periods presented because including them would have been antidilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
2023 |
|
|
October 1,
2022 |
|
|
October 2,
2021 |
|
Stock options to purchase common stock |
|
|
9,449,904 |
|
|
|
6,877,530 |
|
|
|
9,030,004 |
|
Restricted stock units |
|
|
9,742,444 |
|
|
|
5,041,645 |
|
|
|
3,505,140 |
|
Performance stock units |
|
|
149,991 |
|
|
|
88,672 |
|
|
|
55,586 |
|
Total |
|
|
19,342,339 |
|
|
|
12,007,847 |
|
|
|
12,590,730 |
|
|